TrialAmerican journal of respiratory and critical care medicine2018

Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR.

Scott H Donaldson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.